Have a personal or library account? Click to login
Tetranectin as a potential biomarker in heart failure with ejection fraction >45%: A prospective cohort study Cover

Tetranectin as a potential biomarker in heart failure with ejection fraction >45%: A prospective cohort study

Romanian Journal of Internal Medicine
Volume 63 (2025): Issue 3 (September 2025)
By: Paula Alexandra Vulciu,  Luminita Pilat,  Norberth-Istvan Varga,  Voicu Dascau,  Calin Popa,  Maria-Daniela Mot,  Paula Irina Barata,  Imola Donath Miklos and  Maria Puschita  
Open Access
|Jul 2025
DOI: https://doi.org/10.2478/rjim-2025-0014 | Journal eISSN: 2501-062X | Journal ISSN: 1220-4749
Journal RSS Feed
Language: English
Page range: 251 - 262
Submitted on: May 22, 2025
Published on: Jul 26, 2025
Published by: N.G. Lupu Internal Medicine Foundation
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Tetranectin,
heart failure,
heart failure with preserved ejection fraction,
HFpEF,
heart failure with mildly reduced ejection fraction,
HFmrEF,
left ventricular ejection fraction,
LVEF,
NT-proBNP,
heart failure biomarkers
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Internal medicine, other,
Cardiology,
Gastroenterology,
Rheumatology

© 2025 Paula Alexandra Vulciu, Luminita Pilat, Norberth-Istvan Varga, Voicu Dascau, Calin Popa, Maria-Daniela Mot, Paula Irina Barata, Imola Donath Miklos, Maria Puschita, published by N.G. Lupu Internal Medicine Foundation
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 63 (2025): Issue 3 (September 2025)